West Pharmaceutical Services | WST - Current Liabilities


West Pharmaceutical Services reported $644.3M in Current Liabilities for its fiscal quarter ending in September of 2026.





Current Liabilities Change Date
Align Technology USD 1.91B 4.9M Sep/2026
Baxter International USD 3.81B 218M Sep/2026
Becton, Dickinson and Co. USD 9.54B 139M Sep/2026
Cerus USD 100.8M 12.37M Dec/2025
Charles River Laboratories USD 1.09B 45.49M Sep/2026
Cooper Companies USD 1.87B 61.9M Jun/2026
Dentsply International USD 1.22B 32M Sep/2026
Haemonetics USD 300.84M 37.6M Sep/2026
ICU Medical USD 514.63M 16.27M Sep/2026
Insulet USD 814.4M 70.2M Sep/2026
Integra LifeSciences USD 329M 1.88M Sep/2026
IQVIA Holdings USD 7.78B 1.04B Sep/2026
J&J USD 55.46B 562M Sep/2026
Medtronic USD 11.8B 141M Jun/2026
Merit Medical Systems USD 265.08M 150K Sep/2026
Neogen USD 149.5M 8.7M Jun/2026
OraSure Technologies USD 25.12M 18.96M Jun/2026
Quidel USD 1.07B 73.7M Sep/2026
Repligen USD 125.69M 6.97M Sep/2026
Rockwell Medical USD 10.95M 259K Jun/2025
Solventum Corp USD 3.58B 88M Sep/2026
STAAR Surgical USD 75.54M 2.15M Sep/2026
Terumo JPY 306.08B 107.19B Sep/2026
Utah Medical Products USD 3.5M 907K Mar/2026
West Pharmaceutical Services USD 644.3M 3.8M Sep/2026